Introduction
When a person suffers from an excessive or unreasonable persistent fear directed towards a specific travel-related object (e.g. motorbike) or situation (e.g. travelling as a passenger in a car) that is either present or anticipated, it is likely that this person fulfils the criteria for travel phobia 1 , one of the subtypes of specific phobia (Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR, American Psychiatric Association, 2000). Travel phobia can manifest as fear and avoidance of private means of transport, as well as public transport, and involve car drivers, passengers, motorcyclists, cyclists, and pedestrians (e.g. Ehring, Ehlers, & Glucksman, 2006; Ehring, Ehlers, & Glucksman, 2008; Mayou, 1997; Mayou, Bryant, & Duthie, 1993; Mayou, Bryant, & Ehlers, 2001 ).
In many instances travel phobia and travel-related anxiety arise following a road traffic accident (RTA; Taylor & Deane, 1999) . In relation to travel anxiety resulting from RTAs, reported that, despite the minor severity of most peoples' physical injuries, 22% of their sample of 1148 individuals experienced travel anxiety at 3 months post-accident. This appeared to be a persistent condition with 17% still reporting symptoms at 1 year follow-up, and 14% at 3 years follow-up (Mayou & Bryant, 2002) .
Despite the high prevalence rates of travel phobia and anxiety in the general population, its persistency, and the impact of the constellation of symptoms on a person's functioning (e.g. Mayou et al, 1993) , there has been remarkably little research regarding its treatment. Although in vivo exposure to the phobic stimulus has proven to be the treatment of choice for a variety of specific phobias, empirical evidence on the long-term outcome of in vivo exposure as a treatment of specific phobia is less strong than generally assumed (Choy, Fyer, & Lipsitz, 2007) . Of the in total fourteen controlled outcome studies on specific phobia that have been carried out to date, only eight included a control condition. Moreover, these studies addressed only a limited range of phobia subtypes (i.e.,
1 Previous research has used a variety of other terms to refer to anxiety regarding driving and other forms of travel, including driving phobia or driving-related fear (e.g. Ehlers, Hofmann, Herda, & Roth, 1994; Kuch, Swinson, & Kirby, 1985; Mathew, Weinman, Semchuk, & Levin, 1982; Munjack, 1984; Taylor, 2008; Taylor & Deane, 1999; Taylor, Deane, & Podd, 2002; Townend, 2003; Townend & Grant, 2006) , and accident phobia (e.g. Kuch, 1997; Kuch, Cox, Evans, & Shulman, 1994; Taylor & Koch, 1995) .
animal phobia, water phobia, height phobia, flying phobia, and claustrophobia; Choy et al, 2007) . A randomized controlled trial determining the efficacy of in vivo exposure for travel phobia has never been performed (Wolitzky-Taylor, Horowitz, Powers, & Telch, 2008) . One of the reasons why treatment of travel phobia is not well-studied may be that clinicians feel limited in their ability to accompany patients in a car. For instance, one of the leading providers of professional indemnity insurance for mental health professionals in the UK (Towergate Professional Risks) advise against therapist-assisted exposure during which a patient is confronted with their phobic stimuli, for practical, safety and insurance reasons. They state "there are other interventions which can be utilised instead of requiring the client to drive so you may wish to consider utilising these in preference" (personal communication, November 14, 2008) . Another possible reason why empirical support for in vivo exposure in the context of travel phobia is lacking, is that this procedure may lead to an exacerbation of symptoms. For example, in a study among survivors of the London bombings of 7 July 2005, who subsequently developed a phobia of public transport, it appeared that those who underwent in vivo exposure showed an increase in posttraumatic stress disorder (PTSD) symptoms in the course of their treatment (Handley, Salkovskis & Ehlers, 2008) .
There is a number of alternative cognitive behavioural treatment strategies for travel phobia, including cognitive therapy and the use of computer driving games and virtual reality to implement exposure to driving situations. Using cognitive therapy, Townend (2003) reported the successful treatment of travel phobia in two single cases, of which one developed symptoms following an RTA, and the other after an experience of sudden overwhelming anxiety whilst driving. The therapy focussed on the danger and anxiety expectancies of the patients, safety behaviours and avoidance.
Between 5 and 9 sessions appeared to be effective for both patients as indexed by both psychometric scales and a behavioural measure of driving anxiety. In an extension to this treatment report, Townend and Grant (2006) reported successful treatment of 8 out of 10 cases with travel phobia using cognitive therapy delivered over 8-10 sessions. Walshe and colleagues (Walshe, Lewis, Kim, O'Sullivan, & Wiederhold, 2003) , reported successful treatment of 7 patients with travel phobia using virtual reality combined with cognitive therapy, which required up to 12 sessions.
Patients suffering from travel phobia arising from RTAs per definition have been exposed to an event potentially associated with terror or pain as well as "a threat to one's personal integrity", criteria associated with PTSD (American Psychiatric Association, 2000, p. 463) . Furthermore, the symptomatology of PTSD and travel phobia arising after RTAs have been found to greatly overlap (Ehring, Ehlers, & Glucksman, 2006; McNally & Saigh, 1993; Taylor & Koch, 1995) . Accordingly, it could be argued that at least a proportion of people suffering from travel phobia would benefit from psychological interventions specifically aimed at resolving the memories of their earlier road traffic incident. An example of this approach was used by Blonstein (1988) who combined in vivo exposure, and imaginary exposure during the treatment of a 41-year-old woman with a travel phobia arising following an RTA. Of the 33 weekly sessions, 22 involved imaginary exposure to the memory of the traumatic event, and the remaining sessions were in vivo exposure. Horne (1993) reported on the treatment of 7 patients with travel phobia arising from RTAs, three of whom were also diagnosed with PTSD. Patients received a program of CBT treatment which consisted of elements of imaginary and in vivo exposure, cognitive restructuring and relaxation. The author reported successful treatment outcomes for all patients with treatment being particularly rapid for those without co-morbid PTSD, taking between 6 and 9 sessions. More recently, a study evaluated the treatment of a consecutive case series of 11 individuals referred for clinically significant travel phobia following the London bombings in 2005 (Handley, Salkovskis & Ehlers, 2008) . Patients underwent a programme consisting of 3 to 17 sessions of in vivo exposure presented as behavioural experiments for phobic avoidance alone (n=4), while the others (n=6) also received Cognitive Therapy for PTSD (Ehlers, Clark, Hackman, McManus and Fennel, 2005) which includes focussed work on the trauma memory. The results showed that all 10 patients who completed treatment had returned to their pre-bombing use of transport and reported minimal symptoms. , it was examined whether response to treatment would differ among different road users.
Method

1. Participants
The sample consisted of 184 individuals aged over 18 who had been involved in an RTA, and were experiencing anxiety regarding travel as a result. Patients were referred to a psychological rehabilitation provider by insurance companies and solicitors, and were in the process of making personal injury claims. In the UK it is incumbent on the claimants to engage in appropriate rehabilitation to mitigate their losses.
The main exclusion criterion was the presence of co-morbid PTSD. Data were collected with the understanding and written consent of each subject, and according to the ethical principles described in the declaration of Helsinki. Due to the nature of the referrals, participants were not excluded on the basis of medication use or prior psychological treatment. Patients were aged between 18 and 84, with a mean age of 41 years. There were substantially more females (n = 133) than males (n = 51) in the sample, which is consistent with previous reports that travel anxiety is more common in females than in males Mayou et al, 1991) . See Table 1 for summary details of the sample.
Procedure
The sample consisted of consecutive patients who were allocated to therapists nationwide to receive treatment with either TF-CBT or EMDR. No form of selection or self-selection took place as allocation to therapist, and thus treatment condition, was based on the geographical location of the therapist and the patient. The closest available therapist to the patient was selected on referral to the study, and this determined which treatment the patient received. One hundred and twenty-five people (68%) received TF-CBT, and the remaining 59 (32%) received 'EMDR + in vivo exposure'.
Intake diagnoses for Axis I disorders were established using DSM-IV-TR criteria at initial assessment (American Psychiatric Association, 2000) . Patients with fear of travelling secondary to other anxiety disorders, such as panic disorder, agoraphobia, and PTSD were excluded from the present sample. Diagnosis of specific (i.e. travel) phobia was made by the independent medico-legal expert (a consultant psychiatrist or clinical psychologist) in the first instance before referral and subsequently by the treating therapist as more than six months may have elapsed since the first report. The diagnosis was confirmed by the overseeing clinical psychologist. If patients did not meet all DSM-IV criteria for specific phobia, but displayed anxiety regarding travel-related situations, they were classified in the present research as experiencing travel anxiety.
Treatment was terminated prior to completion in 23% of cases. In the CBT group 31 people (25%), and in the 'EMDR + in vivo exposure' group 11 people (19%) did not complete treatment.
Treatment was terminated early for a variety of reasons including legal settlement of the case, termination by the referring body and by the patient themselves. Overall 142 patients (94 in the TF-CBT group, 48 in the 'EMDR + in vivo exposure' group) completed treatment.
[ Table 1 about here]
Treatment
Treatment was administered by 125 therapists nationwide who were approved to treat patients by the psychological rehabilitation provider which received the referrals. Of these, 87 treated patients were in the TF-CBT group, and 46 treated patients in the 'EMDR + in vivo exposure' group. All therapists were accredited with a professional body (such as the British Association for Behavioural and Cognitive Psychotherapies, UK Council for Psychotherapy, and British Psychological Society), and held approved qualifications in CBT or EMDR respectively.
In TF-CBT, the patient is guided through a vivid remembering of the trauma until extinction occurs.
TF-CBT is generally applied using imaginal and in vivo forms of exposure, as well as elements of cognitive restructuring, relaxation and anxiety management (Rothbaum, Meadows, Resick & Foy, 2000) . Imaginal exposure involves presenting relevant cues in imagery and describing details of an event or set of events. In vivo exposure can be applied as homework tasks and behavioural experiments to reduce avoidance and promote the opportunity to evoke mastery through observing that no real danger exists. In the present study, imaginal exposure was applied during sessions, as well as cognitive restructuring and anxiety management techniques, and in vivo homework was given, for which patients were expected to confront situations regularly without the therapist (e.g., returning to the scene of the accident or self-exposure to cars or other anxiety provoking cues). In vivo exposure during treatment sessions (e.g., therapist accompanying the client driving a car) was discouraged for safety and insurance reasons.
In EMDR patients are requested to attend to a distracting (or "dual attention") stimulus. Typically the patient is requested to visually track the therapist's fingers moving from side to side in front of the patient's eyes, while holding in mind a memory of a distressing event. Rather than providing a narrative of the details of the event, as is done in TF-CBT, patients are encouraged to follow their own course, moving freely in time, attending to emotions, inner sensations and cognitions, thereby omitting verbal communication about the content if they wish. The EMDR procedure is an eight phase protocol (Shapiro, 2001 ) involving a three pronged approach of past, present, and future. It includes the following steps: (a) alleviating the distress related to one or more old memories, (b) deconditioning the effects of present stimuli that trigger the fear response, and (c) preparing the patient for future confrontations with the conditioned stimuli by self-managed homework assignments in a similar way as was done in the TF-CBT condition. Therefore, the intervention was named 'EMDR + in vivo exposure'.
Treatment was administered in one hour sessions, given weekly in the majority of cases. However, some patients experienced longer delays between sessions due to other commitments and illness.
No manualized treatment protocols were used, and due to the wide network of therapists administering treatment, no evaluation of treatment fidelity was possible. However, monthly reports of all individual patients' treatment were assessed by a clinical psychologist (MH) with extensive training in and experience of both CBT and EMDR, in order to monitor adherence to treatment protocols. No maximum was imposed regarding the number of sessions which could be administered. Instead, monthly progress reports and frequent contact with therapists was maintained, and patients were considered to have completed treatment either a) when they reached good end-state functioning, defined as scoring in the 'normal' range on the psychometrics and no longer experiencing significant anxiety regarding travel, i.e. being able to use their preferred mode of travel on all types of roads and road conditions during their treatment time or b) when it was agreed that the patient's improvement had plateaued or they were unlikely to make significant further progress in treatment. This usually implied that they were able to use their preferred mode of travel but that they, for example, chose not to use motorways, but only adhere to local roads.
Measures
Outcome measures were as follows: drop-out rate, number of treatment sessions required, therapist rating of outcome, and a range of self-report psychometric measures. Therapist-rated outcome was measured on a four-point Likert-type scale, on which the treating therapist indicated the degree of progress made by the patient at discharge (i.e. 'successful', 'good progress', 'some improvement'
and 'no improvement'). In order to receive a rating of 'successful' patients had to demonstrate good end-state functioning (i.e., returned to their pre-accident adjustment related to road travel). To receive a rating of 'good progress', the patient had to display behavioural change regarding their phobia (i.e., travel on local roads or with specific drivers). A number of psychometric self-report measures were taken at initial assessment (prior to treatment commencement), after every four sessions, and at discharge (when patients were judged to have clinically completed treatment).
These were as follows:
General Health Questionnaire (GHQ28): The GHQ-28 (Goldberg & Hillier, 1979 give a range of 0-7 for each subscale, and 0-28 for the total score.
Impact of Event Scale (IES):
The IES (Horowitz, Wilner, & Alvarez, 1979 ) is a self-report scale which measures the psychological impact of a traumatic event on an individual and is one of the most widely used self-report instruments of posttraumatic stress (Joseph, 2000) . The IES consists of 15 items which evaluate symptoms of intrusions (e.g. "Pictures about it popped into my mind") and avoidance (e.g. "I stayed away from reminders about it") related to a traumatic event. Items are rated on a four-point scale of frequency, ranging from 'not at all' (0), 'rarely' (1), 'sometimes' (3) to 'often' (5). The scores are summed to produce a range of 0-75 for the total score.
Hospital Anxiety and Depression Scale (HADS):
This commonly used scale, developed by Zigmond & Snaith (1983) , is a 14-item questionnaire, of which 7 items measure the frequency of anxiety symptoms (e.g. "Worrying thoughts go through my mind"), and the remaining items measure depression symptoms (e.g. "I look forward with enjoyment to things"). Items are scored on a 4 point scale of frequency or agreement, giving a range of 0-21 for each subscale, and 0-42 for the total score.
Analytic strategy
Baseline analyses were conducted using Pearson's chi-square and t-tests to compare the CBT and 'EMDR + in vivo exposure' groups on baseline measures. Each of the outcome measures was then analysed to explore differences between treatment groups, and those with travel phobia compared with travel anxiety. For all except drop-out rate, completers' analyses were undertaken first, followed by intention-to-treat (ITT) analyses conducted using a last-observation-carried-forward procedure (LOCF) to impute missing data.
In order to compare the effect of treatment on the scores on the psychometric measures, and differences in treatment effects between the diagnoses, one method would have been to use ANCOVA on the scores at discharge, using scores at initial assessment as covariates. However, ANCOVA could not be conducted due to violation of the homogeneity of regression slopes assumption, rendering this analysis inappropriate (Pallant, 2007) . Thus, mixed ANOVAs were conducted on each scale, with time (initial assessment, discharge) as a within-subjects factor, and treatment and diagnosis as between-subjects factors.
Pearson's chi-square analysis was used for categorical outcome measures. Finally, the impact of type of road user (i.e. passenger, driver, motorcyclist etc.) was explored in a set of analyses using ANOVA and chi-square.
Effect sizes for the pre-to post-treatment comparison were calculated for the total score on the each of the psychometrics using Cohen's d, and Cohen's (1988) guidelines for magnitude (i.e. small = .2, medium = .5, large = .8). These are reported separately for each treatment.
Clinically meaningful change was calculated in two ways. Firstly, by considering the proportion of patients scoring in the disordered range on each psychometric scale's total score at initial assessment, and whose scores had dropped into the normal range by discharge. Patients' total scores on the GHQ, IES and HADS were classified as being in the normal or disordered range at initial assessment and discharge as follows: on the GHQ if they fell below 13, on the IES if they fell below 27, and on the HADS if they fell below 16. The proportion of patients whose scores fell to within the normal range was compared between treatment groups using Pearson's chi-square. Secondly, the degree of change during treatment was assessed using Jacobson & Truax's (1991) description of a "reliable change index", proposed by Christensen and Mendoza (1986) . Reliable change (RC) was calculated as the initial assessment score -discharge score / standard error of this difference. If the RC exceeded 1.96 then the post-treatment score was considered likely to reflect a real and clinically meaningful change for that patient. Again this was compared between treatment groups using Pearson's chi-square. All analyses reported were assessed using an alpha of .05.
Results
Baseline differences
Initial analyses revealed no difference in the number of males and females in each group, χ 2 (1) = 2.69, p = .10, or in the proportion of patients with travel phobia and anxiety in each group, χ 2 
Drop-out rate
As previously noted, treatment was terminated early in 42 cases for a variety of reasons, including legal settlement and termination of treatment by the referring body. However, notably few cases were terminated by the patient themselves. Overall only 11.4% of patients dropped out of treatment:
17 patients (13.6%) in the CBT group and 4 patients (6.8%) in the 'EMDR + in vivo exposure' group. In total, in the CBT group 94 patients (75.2%) completed treatment, and in the 'EMDR + in vivo exposure' group 48 patients (81.4%) completed. Chi-square analysis examined the proportions of completers, drop-outs and other terminations between the two treatment groups and the two diagnostic groups, and found no differences due to treatment [χ 2 (2) = 1.85, p = .40] or diagnosis [χ 2 (2) = 3.60, p = .17].
Completer analysis
3.3.1. Self-report psychometrics Mixed ANOVAs were conducted on each scale, with score as the dependent variable, time (initial assessment, discharge) as a within-subjects factor, and treatment and diagnosis as between-subjects factors. Means and standard deviations split by diagnosis and treatment for the total scores on the GHQ, IES and HADS are shown in On the total score for each scale, the effect sizes for the two treatments were calculated for the preto post-treatment comparison. These effect sizes, shown in Table 3 , were very large for both treatments, and were slightly larger for the CBT group than the 'EMDR + in vivo exposure' group.
[ Table 2 about here] 3.3.2. Therapist-rated outcome Therapist-rated outcome indicated that both treatments were highly effective. Overall, 67.6% of cases were rated as being 'successful' by the treating therapist (i.e. having reached good end-state functioning), 21.8% were rated as having made 'good progress', and 8.5% were rated as 'some improvement'. Only 2.1% (i.e. 3 patients) made no improvement during treatment. A comparison was then conducted of the number of patients receiving each of the four levels of therapist-rated outcome between the two treatment groups, and the two diagnostic groups. Chi-square analysis revealed no significant difference in rated outcome between the diagnoses [χ 2 (3) = 1. 
Intention-to-treat analysis
Intention-to-treat analyses revealed no qualitative differences to the completer analyses, except that the 3-way interaction for the HADS total score was no longer significant [F (1,124) = 2.51, p = .12].
The effect sizes for the effects of treatments from initial assessment to discharge remained very large, as in the completer analysis, as shown in Table 3 . Only the effect size for the IES was larger for the CBT group than the 'EMDR + in vivo exposure' group.
[ Table 3 about here]
Clinically significant change
In order to examine clinically significant change, the number of patients in each treatment group who scored in the disordered range at initial assessment, and whose scores had decreased into the normal range at discharge, was analysed, and are presented in Table 4 . The only significant difference in these proportions was on the IES, specifically for those with travel anxiety. On this measure, more travel anxiety cases moved into the normal range at discharge in the CBT group (90.9%) than in the 'EMDR + in vivo exposure' group (61.5%). The results of analyses concerning the Reliable Change Index (Jacobson & Truax, 1991) are presented in Table 5 . On all the scales, over 70% of patients' scores changed reliably. As can be seen, there were no significant differences between treatments in these proportions.
[ Tables 4 and 5 about here]
Differences between road users
From Table 1 it is clear that the majority of patients were either drivers or passengers at the time of the accident. Only 23 patients were motorcyclists, pedestrians, cyclists or horse riders. Therefore, analysis of road user group was restricted to a comparison of drivers and passengers due to very small numbers in the other groups. In total there were 107 drivers, of which 85 completed treatment, and 52 passengers, of which 39 completed treatment. There was no difference in the number of sessions required [t (122) = 0.42, p = .67; Drivers: M = 8.18 sessions, SD = 3.92;
Passengers: M = 8.49 sessions, SD = 3.51]. There was also no difference in the therapist-rated outcomes for these groups [χ 2 (3) = 2.23, p = .53]. Of the drivers, 67.9% were rated as successful, 23.8% made good progress, 7.1% made some improvement and only 1.2% made no improvement.
In the passengers group, 59.0% were successful, 28.2% made good progress, 7.7% made some improvement and 5.1% made no improvement.
Examining the results from the self-report psychometrics, some differences between drivers and passengers emerged. ANOVA with time (initial assessment, discharge) as a repeated measures factor and road user group (drivers, passengers) as a between-subjects factor was conducted for the total score on each scale. On the GHQ, the effect of time was significant [F (1,101) = 97.41, p <
.001], but the effect of road user group and the interaction of these factors were non-significant (Fs < 1). Results for the HADS were similar, with a significant effect of time [F (1,93) = 87.97, p <
.001], but a non-significant effect of road user group and interaction (Fs < 1). Therefore, scores on both the GHQ and HADS did not differ between drivers and passengers, and the reduction in scores between initial assessment and discharge was not significantly different between these groups.
However, on the IES, the effect of road user group was significant [F (1,102) = 6.42, p = .01], although the interaction with time was non-significant [F (1,102) = 0.02, p = .89]. As shown in Figure 1 , scores at both initial assessment and discharge were higher for passengers than drivers, but the effect of treatment did not differ.
[ Figure 1 about here]
Discussion
This is probably the largest treatment study on travel phobia and travel anxiety to date, and the first study to investigate the applicability of two evidence-based psychological interventions for these conditions. The results show that both TF-CBT and 'EMDR + in vivo exposure' were followed by a clear reduction of symptomatology as indexed by therapist/patient ratings, and validated measures among both patients with specific phobia, and those with milder forms of travel anxiety. These improvements could be obtained within an average course of 7.3 sessions. This is somewhat lower in comparison with previous reports of up to 12 sessions of CBT treatment for travel phobia in case studies and studies with small samples (Horne, 1993; Townend, 2003; Townend & Grant, 2006; Walshe et al., 2003) . No indications were found that one treatment would be more beneficial than the other in terms of reduction of symptoms of anxiety, depression, PTSD, or other indicators of functioning. However, patients with travel phobia responded with a greater reduction of anxiety and PTSD symptoms than those with less severe forms of travel anxiety.
Although CBT has been proven to be efficacious for treatment of specific phobias (Choy et al, 2007; Wolitzky-Taylor et al, 2008) , data indicating positive treatment effects in case of treating travel phobia is limited to a very small number of case studies. In all of these cases in vivo exposure was the core of the treatment protocol. Accordingly, an important outcome of the present study is that neither treatment condition involved formal in vivo exposure during treatment sessions. This suggests that a trauma-focused treatment approach for travel anxiety arising from road traffic accidents can be a viable option. Until now, exploration of the use of a trauma-focused approach for other conditions than PTSD has been very limited. The chief difference with in vivo exposure is that in the latter case patients are requested to focus their attention on the fear-evoking stimulus (CS) to investigate its predictive value, whereas in EMDR or TF-CBT, the focus is the memory of the traumatic incident that caused the fear response (representation of the UCS/UCR). Although it can not be ruled out that homework assignments contributed to the treatment results, the present results support the claim that a trauma-focused treatment approach may be suitable for unprocessed memories which underlie not only PTSD, but also other types of anxiety disorders that developed following a distressing event (De Jongh, Ten Broeke, & Renssen, 1999; De Jongh, Van den Oord, & Ten Broeke, 2002; De Jongh & Ten Broeke, 2009 ).
CBT for travel phobia might include returning to the scene of the accident with the patient driving (Blanchard & Hickling, 1997) . However, therapist-assisted in vivo exposure in the present study was not encouraged due to safety and insurance issues precluding clinicians from accompanying patients in cars (Towergate Professional Risks, personal communication, November 14, 2008) .
Despite this potential limitation, it would seem that through the application of imaginal exposure and other elements of their treatment, many patients in both treatment conditions felt safe and enabled enough to carry out their homework assignments, encountering travel-related situations on their own. These included activities such as returning to the site of the accident or driving their car or motorcycle again. For example, in one particular case, a 31 year-old man was knocked from his motorbike and subsequently developed a phobia of travelling by motorbike. He attempted to travel as a car passenger to work instead, but this also evoked high levels of anxiety. Eventually his family moved house so he could travel to work by tube. During treatment he started with homework exposure tasks, and at discharge from treatment he was able to ride his motorbike again with confidence in a variety of situations, and considered himself "over 90% confident in all vehiclerelated situations".
Analysis of the effect of road user group on treatment outcome showed that symptoms of trauma may be a particular problem for those who were passengers at the time of the accident. Passengers' scores on the IES showed that they reported more trauma-related symptoms than drivers did. This supports previous research which has shown that passengers are particularly susceptible to travel anxiety compared to other types of road user , perhaps due to a greater sense of lack of control compared to drivers at the time of the accident. Therefore, people who are passengers during an RTA may be particularly at risk of negative psychological reactions to trauma, and as such may be more likely to require treatment for such problems than other types of road users. However, the results suggest no differential treatment effects regarding drivers and passengers on any measure. Hence, while passengers may be particularly affected by RTAs, treatment should be offered to all patients with travel anxiety or phobia, regardless of class of road user during the RTA.
A number of limitations of the current research should be acknowledged. Firstly, due to the absence of manualized treatment protocols it is not clear whether the therapists all uniformly practiced a standardized CBT versus. EMDR treatment for travel phobia. The therapists were certified in TF-CBT or EMDR, and monthly reports of all individual patients' treatment were assessed in order to monitor adherence to treatment protocols. However, since formal treatment integrity checks were not performed, the interventions could have been variable in terms of how competently the therapists performed their respective treatments. Secondly, the absence of a no-treatment control group made it impossible to rule out the threat regression to the mean, or to refute the explanation that the results were not due to therapy, but simply to time or therapist contact. However, with regard to the latter we would suggest this is unlikely since in the majority of cases (67%) the anxiety had persisted for more than a year, and had not resolved in the absence of intervention.
Further, both treatment approaches produced clinically relevant and statistically significant reductions in a variety of symptoms. Most patients (i.e. 31 out of 46) appeared to make good progress by the end of treatment, the size of the treatment effects appears to be large, and larger than would be expected from being the result of non specific effects alone. Yet, due to the lack of follow-up assessments it is not impossible that individual patients who initially showed good treatment outcome benefits experienced a later relapse. Thirdly, the lack of randomization to the two treatments limits any kind of conclusions that can be drawn from the results from each treatment. Clearly, non-randomization was an unfortunate result of the community treatment setting. Although the fact that patients were allocated based on the availability of a therapists in the area where they lived may have limited the occurrence of systematic differences between the groups, the question of relative efficacy remains unanswered. Accordingly, the data should be considered a precursor to more rigorous outcome research such as establishing the relative efficacy of TF-CBT or EMDR versus a pure in vivo exposure approach by means of a randomized controlled trial. Fourthly, it is unclear to what extent the fact that patients were in the process of seeking compensation for personal injury may have influenced their motivation for treatment as well as their reporting of symptoms before and after treatment. For example, it is not impossible that patients had been motivated to exaggerate their symptom reports at the beginning of treatment as this could have helped their personal injury claims. Fifthly, treatment was terminated when further therapist contact was not considered necessary. However, we were unable to use blind raters of outcome, as data was collected by the treating therapists who were located nationally. In addition, diagnoses were not assessed using structured clinical interviews, and no specific phobia scales or measures of behavioral outcome were used. This means that the main outcome variable was not directly assessed. Therefore, it may be that, albeit psychometric scores fell following treatment, this was not matched by behavioural change regarding travel. However, reported behavioural change was required for therapists/patients to give an outcome rating of 'successful' or 'good progress'.
Nevertheless, future studies should aim to employ specific behavioural outcome measures which can be directly compared across treatments. Finally, it was hoped that patients would continue to expose themselves to phobic situations as they had been doing during treatment, and that their improvement would continue post-treatment. Unfortunately, this was not assessed because there was no permission from the insuring parties to do this. It would be interesting in future research to consider post-treatment progress and long-term outcomes from trauma-focused treatment for specific phobias.
Despite these limitations, one strength of the present study is that patients were drawn from the real world of clinical practice, thereby increasing the generalizability of the findings. At least one other strength which should not remain unmentioned is the inclusion of drop-outs in the outcome analyses. Most treatment outcome studies on specific phobias are based on study completers and fail to report intent-to-treat data (Hofmann & Smits, 2008) . It is well known that patients with specific phobia tend not to seek treatment. Therefore, taking into account treatment motivation and adherence may help to decide which interventions are most suitable for particular patients and clinical circumstances.
Taken together, the present findings suggest that travel phobia and milder forms of travel anxiety following RTAs should be regarded as treatable psychological conditions if appropriate traumafocused psychological treatment is provided. TF-CBT and EMDR, which in the present study was combined with homework assignments, both proved to be beneficial, requiring a limited number of sessions. Given the fact that RTA's are one of the main causes of posttraumatic stress and related psychopathology in Western countries with potentially far reaching clinical, social, economical and employment consequences, and that there is a complete lack of controlled studies supporting the effectiveness of psychological interventions for travel phobia, more rigorous outcome research is warranted and urgently needed. 
